NON-HODGKIN LYMPHOMA
Clinical trials for NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for untreated lymphoma patients
Disease control CompletedThis study tested a combination of three targeted drugs (mosunetuzumab, polatuzumab vedotin, and obinutuzumab) in 42 people with untreated slow-growing B-cell non-Hodgkin lymphoma. The goal was to see how many patients achieved a complete response (no cancer detected). The drugs …
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 16, 2026 22:36 UTC
-
Personalized plans boost survival odds for older stem cell patients
Disease control CompletedThis study tested a personalized geriatric optimization plan (GO!) in 30 adults aged 60 and older who were getting a donor stem cell transplant for blood cancers or bone marrow failure. The plan included tailored advice on diet, sleep, activity, and medications to improve physica…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 13:01 UTC
-
New Two-Step transplant shows promise for tough blood cancers
Disease control CompletedThis study tested a two-step stem cell transplant for people with high-risk blood cancers like leukemia and lymphoma. First, patients got low-dose chemotherapy and radiation to prepare the body. Then, they received donor stem cells and immune cells to help destroy remaining cance…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
Radiation boosts CAR-T: new hope for stubborn lymphoma
Disease control CompletedThis study tested whether giving focused radiation to leftover cancer spots after CAR-T cell therapy could help people with hard-to-treat non-Hodgkin lymphoma. Fourteen adults who still had signs of disease 30 days after CAR-T received radiation. The goal was to see if this appro…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Scientists hunt for clues to why immunotherapy fails in most patients
Knowledge-focused CompletedThis study looked at 135 people with advanced lung cancer, lymphoma, or other tumors treated with immunotherapy drugs called checkpoint inhibitors. Researchers collected blood and tumor samples over time to measure immune cells and molecules that might predict whether the treatme…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC
-
Which donor search strategy saves more lives?
Knowledge-focused CompletedThis study looked at 1,753 patients with blood cancers or other blood disorders who needed a stem cell transplant. Researchers compared two strategies: first searching for a matched unrelated donor and then an alternative donor if needed, versus going straight to an alternative d…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: NA • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:51 UTC
-
New EHR tool sparks Heart-Health talks for cancer survivors
Knowledge-focused CompletedThis study tested whether a special computer tool (AH-HA) could help doctors and cancer survivors talk more about heart health. About 645 survivors of breast, prostate, colorectal, endometrial, or lymphoma cancers took part. The tool aimed to increase discussions, referrals to he…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:09 UTC
-
Lymphoma survivors try online workouts to boost heart health
Knowledge-focused CompletedThis study tested whether lymphoma survivors could safely do exercise at home with online coaching to improve their heart health. Ten survivors who had finished cancer treatment 2-5 years ago took part. The goal was to see if they would stick with the program and if it helped the…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC